Tag: risk adjusted NPV
-
Hit Discovery and Lead Optimization – how teams turn a validated target into an actual drug candidate
This is Part 3 of The Drug Development Playbook. We answer the next question: how do you find molecules that not only hit that biology but can become safe, manufacturable medicines?
-
Disease Understanding and Target Identification: Picking the Biology Worth Backing
This is Part 2 of The Drug Development Playbook, an eight-part series on how medicines actually move from idea to patient use and how smarter decisions at each stage change outcomes.
Aryan Kenia 